Leucocyte-associated immunoglobulin-like receptor-1 is an inhibitory regulator of contact hypersensitivity

Immunology

Volumn 128, Issue 4, 2009, Pages 543-555

  Omiya, Ryusuke ^b,c   Tsushima, Fumihiko ^c   Narazaki, Hidehiko ^c   Sakoda, Yukimi ^b   Kuramasu, Atsuo ^b   Kim, Youn ^b   Xu, Haiying ^b   Tamura, Hideto ^d   Zhu, Gefeng ^b   Chen, Lieping ^c   Tamada, Koji ^a,b,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Co signal molecule; Contact hypersensitivity; Dendritic cells; LAIR 1; T cells

Indexed keywords

HAPTEN; HYBRID PROTEIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 6; LEUKOCYTE ASSOCIATED IMMUNOGLOBULIN LIKE RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTACT ALLERGY; CONTACT DERMATITIS; CONTACT SENSITIZATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE MODEL; DONOR; EXTRACELLULAR SPACE; GENETIC SUSCEPTIBILITY; GROWTH INHIBITION; IMMUNOMODULATION; IN VITRO STUDY; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN SYNTHESIS INHIBITION; RECIPIENT; T LYMPHOCYTE ACTIVATION;

ANIMALS; CELL CYCLE; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; DERMATITIS, ALLERGIC CONTACT; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; HAPTENS; IMMUNE TOLERANCE; IMMUNOLOGIC MEMORY; KILLER CELLS, NATURAL; MICE; MICE, TRANSGENIC; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; SPLEEN; T-LYMPHOCYTE SUBSETS;

EID: 70449401593     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2009.03140.x     Document Type: Article

References (49)

1. Meyaard L, Adema GJ, Chang C, Woollatt E, Sutherland GR, Lanier LL, Phillips JH. LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity 1997 7 : 283 290.
2. Poggi A, Tomasello E, Revello V, Nanni L, Costa P, Moretta L. p40 molecule regulates NK cell activation mediated by NK receptors for HLA class I antigens and TCR-mediated triggering of T lymphocytes. Int Immunol 1997 9 : 1271 1279.
3. Maasho K, Masilamani M, Valas R, Basu S, Coligan JE, Borrego F. The inhibitory leukocyte-associated Ig-like receptor-1 (LAIR-1) is expressed at high levels by human naive T cells and inhibits TCR mediated activation. Mol Immunol 2005 42 : 1521 1530.
4. Meyaard L, Hurenkamp J, Clevers H, Lanier LL, Phillips JH. Leukocyte-associated Ig-like receptor-1 functions as an inhibitory receptor on cytotoxic T cells. J Immunol 1999 162 : 5800 5804.
5. Saverino D, Fabbi M, Merlo A, Ravera G, Grossi CE, Ciccone E. Surface density expression of the leukocyte-associated Ig-like receptor-1 is directly related to inhibition of human T-cell functions. Hum Immunol 2002 63 : 534 546.
6. Jansen CA, Cruijsen CW, de Ruiter T, Nanlohy N, Willems N, Janssens-Korpela PL, Meyaard L. Regulated expression of the inhibitory receptor LAIR-1 on human peripheral T cells during T cell activation and differentiation. Eur J Immunol 2007 37 : 914 924.
7. van der Vuurst de Vries AR, Clevers H, Logtenberg T, Meyaard L. Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) is differentially expressed during human B cell differentiation and inhibits B cell receptor-mediated signaling. Eur J Immunol 1999 29 : 3160 3167.
8. Verbrugge A, de Ruiter T, Geest C, Coffer PJ, Meyaard L. Differential expression of leukocyte-associated Ig-like receptor-1 during neutrophil differentiation and activation. J Leukoc Biol 2006 79 : 828 836.
9. Poggi A, Tomasello E, Ferrero E, Zocchi MR, Moretta L. p40-LAIR- 1regulatesthedifferentiationofperipheralbloodprecursorstodendriticcellsinduced bygranulocyte-monocytecolony-stimulatingfactor. Eur J Immunol 1998 28 : 2086 2091.
10. Lebbink RJ, de Ruiter T, Kaptijn GJ, Bihan DG, Jansen CA, Lenting PJ, Meyaard L. Mouse leukocyte-associated Ig-like receptor-1 (mLAIR-1) functions as an inhibitory collagen-binding receptor on immune cells. Int Immunol 2007 19 : 1011 1019.
11. Sathish JG, Johnson KG, Fuller KJ, LeRoy FG, Meyaard L, Sims MJ, Matthews RJ. Constitutive association of SHP-1 with leukocyte-associated Ig-like receptor-1 in human T cells. J Immunol 2001 166 : 1763 1770.
12. Lebbink RJ, de Ruiter T, Verbrugge A, Bril WS, Meyaard L. The mouse homologue of the leukocyte-associated Ig-like receptor-1 is an inhibitory receptor that recruits Src homology region 2-containing protein tyrosine phosphatase (SHP)-2, but not SHP-1. J Immunol 2004 172 : 5535 5543.
13. Verbrugge A, Rijkers ES, de Ruiter T, Meyaard L. Leukocyte-associated Ig-like receptor-1 has SH2 domain-containing phosphatase-independent function and recruits C-terminal Src kinase. Eur J Immunol 2006 36 : 190 198.
14. Lebbink RJ, de Ruiter T, Adelmeijer J et al. Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1. J Exp Med 2006 203 : 1419 1425.
15. Skoet R, Zachariae R, Agner T. Contact dermatitis and quality of life: a structured review of the literature. Br J Dermatol 2003 149 : 452 456.
16. Grabbe S, Schwarz T. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol Today 1998 19 : 37 44.
17. Watanabe H, Unger M, Tuvel B, Wang B, Sauder DN. Contact hypersensitivity: the mechanism of immune responses and T cell balance. J Interferon Cytokine Res 2002 22 : 407 412.
18. + T cells in contact hypersensitivity and allergic contact dermatitis. Eur J Dermatol 2004 14 : 131 138.
19. Wang B, Feliciani C, Freed I, Cai Q, Sauder DN. Insights into molecular mechanisms of contact hypersensitivity gained from gene knockout studies. J Leukoc Biol 2001 70 : 185 191.
20. O'Leary JG, Goodarzi M, Drayton DL, von Andrian UH. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 2006 7 : 507 516.
21. Gelse K, Poschl E, Aigner T. Collagens - structure, function, and biosynthesis. Adv Drug Deliv Rev 2003 55 : 1531 1546.
22. de Fougerolles AR, Sprague AG, Nickerson-Nutter CL et al. Regulation of inflammation by collagen-binding integrins alpha1beta1 and alpha2beta1 in models of hypersensitivity and arthritis. J Clin Invest 2000 105 : 721 729.
23. Chapoval AI, Zhu G, Chen L. Immunoglobulin fusion proteins as a tool for evaluation of T-cell costimulatory molecules. Mol Biotechnol 2002 21 : 259 264.
24. Zhu G, Flies DB, Tamada K, Sun Y, Rodriguez M, Fu YX, Chen L. Progressive depletion of peripheral B lymphocytes in 4-1BB (CD137) ligand-I-Ealpha)- transgenic mice. J Immunol 2001 167 : 2671 2676.
25. Choi IH, Zhu G, Sica GL et al. Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family. J Immunol 2003 171 : 4650 4654.
26. Wilcox RA, Flies DB, Zhu G et al. Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors. J Clin Invest 2002 109 : 651 659.
27. + type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity. J Immunol 2000 165 : 6783 6790.
28. Koch F, Kampgen E, Schuler G, Romani N. Isolation, enrichment, and culture of murine epidermal langerhans cells. In : Robinson SE, Stagg AJ, eds. Dendritic Cell Protocols. Totowa, New Jersey : Humana Press Inc, 2001 : 43 62.
29. Wilcox RA, Chapoval AI, Gorski KS et al. Cutting edge: expression of functional CD137 receptor by dendritic cells. J Immunol 2002 168 : 4262 4267.
30. Hochrein H, O'Keeffe M, Luft T, Vandenabeele S, Grumont RJ, Maraskovsky E, Shortman K. Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J Exp Med 2000 192 : 823 833.
31. + cytolytic T cells and responsiveness to IL-2 but not cytolytic activity. J Immunol 2002 169 : 4230 4236.
32. Bennett CL, van Rijn E, Jung S, Inaba K, Steinman RM, Kapsenberg ML, Clausen BE. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol 2005 169 : 569 576.
33. Hope JC, Campbell F, Hopkins SJ. Deficiency of IL-2 or IL-6 reduces lymphocyte proliferation, but only IL-6 deficiency decreases the contact hypersensitivity response. Eur J Immunol 2000 30 : 197 203.
34. Riemann H, Schwarz A, Grabbe S et al. Neutralization of IL-12 in vivo prevents induction of contact hypersensitivity and induces hapten-specific tolerance. J Immunol 1996 156 : 1799 1803.
35. Hardin AO, Meals EA, Yi T, Knapp KM, English BK. SHP-1 inhibits LPS-mediated TNF and iNOS production in murine macrophages. Biochem Biophys Res Commun 2006 342 : 547 555.
36. Smith RE, Patel V, Seatter SD et al. A novel MyD-1 (SIRP-1alpha) signaling pathway that inhibits LPS-induced TNFalpha production by monocytes. Blood 2003 102 : 2532 2540.
37. Iwabuchi K, Hatakeyama S, Takahashi A et al. Csk overexpression reduces several monokines and nitric oxide productions but enhances prostaglandin E2 production in response to lipopolysaccharide in the macrophage cell line J774A.1. Eur J Immunol 1997 27 : 742 749.
38. Tsushima F, Yao S, Shin T et al. Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy. Blood 2007 110 : 180 185.
39. Poggi A, Pellegatta F, Leone BE, Moretta L, Zocchi MR. Engagement of the leukocyte-associated Ig-like receptor-1 induces programmed cell death and prevents NF-kappaB nuclear translocation in human myeloid leukemias. Eur J Immunol 2000 30 : 2751 2758.
40. Zhang J, Somani AK, Yuen D, Yang Y, Love PE, Siminovitch KA. Involvement of the SHP-1 tyrosine phosphatase in regulation of T cell selection. J Immunol 1999 163 : 3012 3021.
41. Newman DK, Hamilton C, Newman PJ. Inhibition of antigen-receptor signaling by Platelet Endothelial Cell Adhesion Molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck). Blood 2001 97 : 2351 2357.
42. Chow LM, Fournel M, Davidson D, Veillette A. Negative regulation of T-cell receptor signalling by tyrosine protein kinase p50csk. Nature 1993 365 : 156 160.
43. Latchman Y, Wood CR, Chernova T et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2001 2 : 261 268.
44. Chuang E, Lee KM, Robbins MD et al. Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases. J Immunol 1999 162 : 1270 1277.
45. Boruchov AM, Heller G, Veri MC, Bonvini E, Ravetch JV, Young JW. Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J Clin Invest 2005 115 : 2914 2923.
46. Bates EE, Fournier N, Garcia E et al. APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif. J Immunol 1999 163 : 1973 1983.
47. Ouyang W, Xue J, Liu J et al. Establishment of an ELISA system for determining soluble LAIR-1 levels in sera of patients with HFRS and kidney transplant. J Immunol Methods 2004 292 : 109 117.
48. Poggi A, Catellani S, Bruzzone A, Caligaris-Cappio F, Gobbi M, Zocchi MR. Lack of the leukocyte-associated Ig-like receptor-1 expression in high-risk chronic lymphocytic leukaemia results in the absence of a negative signal regulating kinase activation and cell division. Leukemia 2008 22 : 980 988.
49. Lebbink RJ, van den Berg MC, de Ruiter T, Raynal N, van Roon JA, Lenting PJ, Jin B, Meyaard L. The Soluble leukocyte-associated Ig-like receptor (LAIR)-2 antagonizes the collagen-LAIR-1 inhibitory immune interaction. J Immunol 2008 180 : 1662 1669.